XML 25 R14.htm IDEA: XBRL DOCUMENT
v3.21.1

Leases | 3 Months Ended
--- | ---
Mar. 31, 2021
Leases [Abstract] |
Leases | Leases Lease Income The following table summarizes the Company’s lease income, excluding discontinued operations (in thousands):
| Three Months Ended March 31, |  |
| 2021 |  | 2020 |  |  |  |
Fixed income from operating leases | $ | 262,937 |  |  | $ | 226,226 |  |  |  |  |
Variable income from operating leases | 65,035 |  |  | 56,091 |  |  |  |  |
Interest income from direct financing leases | 2,163 |  |  | 3,269 |  |  |  |  |
Direct Financing Leases Net investment in DFLs consists of the following (dollars in thousands):
| March 31, 2021 |  | December 31, 2020
Present value of minimum lease payments receivable | $ | 7,758 |  |  | $ | 9,804 |
Present value of estimated residual value | 44,706 |  |  | 44,706 |
Less deferred selling profits | (7,758) |  |  | (9,804) |
Net investment in direct financing leases | $ | 44,706 |  |  | $ | 44,706 |
Properties subject to direct financing leases | 1 |  |  | 1 |
Direct Financing Lease Internal Ratings At March 31, 2021, the Company had one hospital under a DFL with a carrying amount of $45 million and an internal rating of performing. 2020 Direct Financing Lease Sale During the first quarter of 2020, the Company sold a hospital under a DFL for $82 million and recognized a gain on sale of $42 million, which is included in other income (expense), net. Lease Costs The following table provides supplemental cash flow information regarding the Company’s leases for which it is the lessee, such as ground leases (dollars in thousands):
|  | Three Months Ended March 31,
Supplemental Cash Flow Information: |  | 2021 |  | 2020
Right-of-use asset obtained in exchange for new lease liability: |  |  |  |
Operating leases |  | $ | 5,020 |  |  | $ | — |
COVID-19 Rent Deferrals During the second and third quarters of 2020, the Company agreed to defer rent from certain tenants in the medical office segment, with the requirement that all deferred rent be repaid by the end of 2020. Under this program, through December 31, 2020, approximately $6 million of rent was deferred for the medical office segment, all of which had been collected as of December 31, 2020. Additionally, through December 31, 2020, the Company granted approximately $1 million of rent deferrals to certain tenants in the life science segment, all of which had been collected as of December 31, 2020. No such deferrals were granted during the three months ended March 31, 2021 and 2020. The rent deferrals granted do not impact the pattern of revenue recognition or amount of revenue recognized (refer to Note 2 for additional information).
Leases | Leases Lease Income The following table summarizes the Company’s lease income, excluding discontinued operations (in thousands):
| Three Months Ended March 31, |  |
| 2021 |  | 2020 |  |  |  |
Fixed income from operating leases | $ | 262,937 |  |  | $ | 226,226 |  |  |  |  |
Variable income from operating leases | 65,035 |  |  | 56,091 |  |  |  |  |
Interest income from direct financing leases | 2,163 |  |  | 3,269 |  |  |  |  |
Direct Financing Leases Net investment in DFLs consists of the following (dollars in thousands):
| March 31, 2021 |  | December 31, 2020
Present value of minimum lease payments receivable | $ | 7,758 |  |  | $ | 9,804 |
Present value of estimated residual value | 44,706 |  |  | 44,706 |
Less deferred selling profits | (7,758) |  |  | (9,804) |
Net investment in direct financing leases | $ | 44,706 |  |  | $ | 44,706 |
Properties subject to direct financing leases | 1 |  |  | 1 |
Direct Financing Lease Internal Ratings At March 31, 2021, the Company had one hospital under a DFL with a carrying amount of $45 million and an internal rating of performing. 2020 Direct Financing Lease Sale During the first quarter of 2020, the Company sold a hospital under a DFL for $82 million and recognized a gain on sale of $42 million, which is included in other income (expense), net. Lease Costs The following table provides supplemental cash flow information regarding the Company’s leases for which it is the lessee, such as ground leases (dollars in thousands):
|  | Three Months Ended March 31,
Supplemental Cash Flow Information: |  | 2021 |  | 2020
Right-of-use asset obtained in exchange for new lease liability: |  |  |  |
Operating leases |  | $ | 5,020 |  |  | $ | — |
COVID-19 Rent Deferrals During the second and third quarters of 2020, the Company agreed to defer rent from certain tenants in the medical office segment, with the requirement that all deferred rent be repaid by the end of 2020. Under this program, through December 31, 2020, approximately $6 million of rent was deferred for the medical office segment, all of which had been collected as of December 31, 2020. Additionally, through December 31, 2020, the Company granted approximately $1 million of rent deferrals to certain tenants in the life science segment, all of which had been collected as of December 31, 2020. No such deferrals were granted during the three months ended March 31, 2021 and 2020. The rent deferrals granted do not impact the pattern of revenue recognition or amount of revenue recognized (refer to Note 2 for additional information).

X
- References No definition available. + Details
Name: | us-gaap_LeasesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of lessor's direct financing leases. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 30 -URI http://asc.fasb.org/subtopic&trid=77888252 + Details
Name: | us-gaap_LessorDirectFinancingLeasesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for lessor's operating leases. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 10 -Section 55 -Paragraph 40 -Subparagraph Note 1 -URI http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 10 -Section 55 -Paragraph 40 -Subparagraph Note 3 -URI http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 30 -URI http://asc.fasb.org/subtopic&trid=77888252 + Details
Name: | us-gaap_OperatingLeasesOfLessorDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration